# A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)

> **NCT07292246** · NA · RECRUITING · sponsor: **Vasileios Kalles** · enrollment: 15 (estimated)

## Conditions studied

- Breast Cancer
- BRCA 1 Gene Mutation
- BRCA 2 Gene Mutation
- Hereditary Breast Carcinoma
- Breast Neoplasms
- DCIS
- Germline Mutation Abnormality
- Early Breast Cancer

## Interventions

- **PROCEDURE:** Endoscopic nipple sparing mastectomy
- **DEVICE:** HandX endoscopic instrument

## Key facts

- **NCT ID:** NCT07292246
- **Lead sponsor:** Vasileios Kalles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-09
- **Primary completion:** 2028-10
- **Final completion:** 2029-10
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07292246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07292246, "A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07292246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*